136 related articles for article (PubMed ID: 8143616)
1. Somatic cell gene mutations in humans: biomarkers for genotoxicity.
Albertini RJ; Nicklas JA; O'Neill JP
Environ Health Perspect; 1993 Oct; 101 Suppl 3(Suppl 3):193-201. PubMed ID: 8143616
[TBL] [Abstract][Full Text] [Related]
2. In vivo mutations in human blood cells: biomarkers for molecular epidemiology.
Albertini RJ; Nicklas JA; Fuscoe JC; Skopek TR; Branda RF; O'Neill JP
Environ Health Perspect; 1993 Mar; 99():135-41. PubMed ID: 8319611
[TBL] [Abstract][Full Text] [Related]
3. Human in vivo somatic mutation measured at two loci: individuals with stably elevated background erythrocyte glycophorin A (gpa) variant frequencies exhibit normal T-lymphocyte hprt mutant frequencies.
Bigbee WL; Fuscoe JC; Grant SG; Jones IM; Gorvad AE; Harrington-Brock K; Strout CL; Thomas CB; Moore MM
Mutat Res; 1998 Feb; 397(2):119-36. PubMed ID: 9541637
[TBL] [Abstract][Full Text] [Related]
4. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
[TBL] [Abstract][Full Text] [Related]
5. Ionizing radiation and genetic risks. III. Nature of spontaneous and radiation-induced mutations in mammalian in vitro systems and mechanisms of induction of mutations by radiation.
Sankaranarayanan K
Mutat Res; 1991 Jul; 258(1):75-97. PubMed ID: 2023601
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of mutations at the HPRT and TK loci of human lymphoblastoid cells after combined treatments with 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosinedagger.
Meng Q; Su T; O'Neill JP; Walker VE
Environ Mol Mutagen; 2002; 39(4):282-95. PubMed ID: 12112380
[TBL] [Abstract][Full Text] [Related]
7. V(D)J recombinase-mediated HPRT mutations in peripheral blood lymphocytes of normal children.
Finette BA; Poseno T; Albertini RJ
Cancer Res; 1996 Mar; 56(6):1405-12. PubMed ID: 8640832
[TBL] [Abstract][Full Text] [Related]
8. HPRT mutations in humans: biomarkers for mechanistic studies.
Albertini RJ
Mutat Res; 2001 Oct; 489(1):1-16. PubMed ID: 11673087
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of somatic mutations in human umbilical cord blood to maternal environments.
Manchester DK; Nicklas JA; O'Neill JP; Lippert MJ; Grant SG; Langlois RG; Moore DH; Jensen RH; Albertini RJ; Bigbee WL
Environ Mol Mutagen; 1995; 26(3):203-12. PubMed ID: 7588645
[TBL] [Abstract][Full Text] [Related]
10. Multiple biological markers in germ cell tumor patients treated with platinum-based chemotherapy.
Perera FP; Motzer RJ; Tang D; Reed E; Parker R; Warburton D; O'Neill P; Albertini R; Bigbee WL; Jensen RH
Cancer Res; 1992 Jul; 52(13):3558-65. PubMed ID: 1319825
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Hprt mutations in cDNA and genomic DNA of T-cell mutants from control and 1,3-butadiene-exposed male B6C3F1 mice and F344 rats.
Meng Q; Walker DM; Scott BR; Seilkop SK; Aden JK; Walker VE
Environ Mol Mutagen; 2004; 43(2):75-92. PubMed ID: 14991748
[TBL] [Abstract][Full Text] [Related]
12. Analysis of in vivo mutation in the Hprt and Tk genes of mouse lymphocytes.
Dobrovolsky VN; Shaddock JG; Heflich RH
Methods Mol Biol; 2014; 1105():255-70. PubMed ID: 24623234
[TBL] [Abstract][Full Text] [Related]
13. Radiation quality affects the efficiency of induction and the molecular spectrum of HPRT mutations in human T cells.
Albertini RJ; Clark LS; Nicklas JA; O'Neill JP; Hui TE; Jostes R
Radiat Res; 1997 Nov; 148(5 Suppl):S76-86. PubMed ID: 9355860
[TBL] [Abstract][Full Text] [Related]
14. Mutant frequency and mutational spectra in the Tk and Hprt genes of N-ethyl-N-nitrosourea-treated mouse lymphoma cellsdagger.
Chen T; Harrington-Brock K; Moore MM
Environ Mol Mutagen; 2002; 39(4):296-305. PubMed ID: 12112381
[TBL] [Abstract][Full Text] [Related]
15. Frequencies of HPRT- lymphocytes and glycophorin A variants erythrocytes in Fanconi anemia patients, their parents and control donors.
Sala-Trepat M; Boyse J; Richard P; Papadopoulo D; Moustacchi E
Mutat Res; 1993 Sep; 289(1):115-26. PubMed ID: 7689157
[TBL] [Abstract][Full Text] [Related]
16. Multiple endpoints for somatic mutations in humans provide complementary views for biodosimetry, genotoxicity and health risks.
Jensen RH; Bigbee WL; Langlois RG
Prog Clin Biol Res; 1990; 340C():81-92. PubMed ID: 2381942
[TBL] [Abstract][Full Text] [Related]
17. Frequency and spectrum of ethylnitrosourea-induced mutation at the hprt and lacI loci in splenic lymphocytes of exposed lacI transgenic mice.
Walker VE; Gorelick NJ; Andrews JL; Craft TR; deBoer JG; Glickman BW; Skopek TR
Cancer Res; 1996 Oct; 56(20):4654-61. PubMed ID: 8840980
[TBL] [Abstract][Full Text] [Related]
18. Quantification and molecular characterization of hprt mutants of human T-lymphocytes.
Moore MM; Harrington-Brock K; Zimmerman LJ; Burnette LP; Smith TW; Everson RB; O'Neill JP; Fuscoe JC
Environ Health Perspect; 1993 Oct; 101 Suppl 3(Suppl 3):219-24. PubMed ID: 8143621
[TBL] [Abstract][Full Text] [Related]
19. A new T-lymphocyte cloning assay for detection of in vivo mutations in the human hypoxanthine-guanine phosphoribosyltransferase gene.
Uematsu K; Yasuda J; Sekine T; Sugano K; Kudoh S; Sekiya T
Environ Mol Mutagen; 1997; 30(1):31-9. PubMed ID: 9258327
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of hypoxanthine guanine phosphoribosyltransferase mutant T cells in human blood: The concept of surrogate selection for immunologically relevant cells.
Kaitz NA; Zuleger CL; Yu P; Newton MA; Albertini RJ; Albertini MR
Mutat Res Rev Mutat Res; 2022; 789():108414. PubMed ID: 35690417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
